King Pharmaceuticals Inc.

(NYSE:KG)

Key Stats & Ratios

Valuation
Market Cap 2.66B
P/E 10.20
P/E (Trailing) 9.84
P/E (Forward)
Price/Sales 1.52
Price/Book 0.97
EPS 1.06
EPS Growth (ttm) 47.00%
Fiscal Year
Fiscal Year Ends Dec 31
Last Quarter Jun 2008
Profitability
Operating Income 351.76M
Net Income 258.22M
Profit Margin (ttm) 14.80%
Operating Margin (ttm) 0.20%
Management Effectiveness
Return on Assets (ttm) 7.40%
Return on Equity (ttm) 9.40%
EBIT Margin (ttm) 22.50
Memberships
S&P 500, Russel 1000
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 1.83B
Revenue 1.75B
Revenue/Share 7.10
Revenue Growth (ytd) -24.10%
Annual Revenue Growth Rate (3Y) 2.37%
Annual Income Growth Rate (3Y) 13.92%
Earnings Growth (ytd) 53.70%
Gross Operating Profit (ttm) 1.32B
EBITDA 656.11M
Diluted EPS (ttm) 1.06
Balance Sheet
Total Cash 1.23B
Total Cash/Share 5.00
Total Assets 3.51B
Total Liabilities 778.89M
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.15
Current Ratio 5.00
Leverage Ratio 1.00
Book Value/Share 11.09
Cash Flow
Cash Flow 434.14M
Free Cash Flow 296.43M
Cash Flow/Share 1.76
Free Cash Flow/Share 1.20

Trading Information

Stock Price History
Beta
52Wk Change -3.30%
52Wk Change Vs. Mkt 45.00%
52Wk High 12.60
52Wk Low 6.98
10 Day Moving Average 10.43
200 Day Moving Average 9.90
Share Statistics
Average Volume 2.57M
Shares Outstanding 246.48M
Shares Float 245.00M
% Held by Insiders 0.60%
% Held by Institutions 95.90%
Shares Short (As of Dec 10, 2008) 11.18M
Short Ratio 3.00
Short % of Float 4.60%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount